Brief HIV Prevention Counseling for STI Patients in South Africa

Status Completed

Clinical Trial Summary

This is a randomized trial to test a brief single session risk reduction counseling intervention on HIV and STI behavioral outcomes in Cape Town South Africa.

Clinical Trial Description

This 5 year study will conduct a randomized clinical trial of a gender and culturally tailored theory-based behavioral risk reduction intervention for men and women who are receiving sexually transmitted infection (STI) diagnostic and treatment services from STI treatment providers in South Africa. As many as one in five South Africans is HIV positive and there are an estimated 1,500 new HIV infections in South Africa each day. The experimental intervention in this study was developed by South African and US investigators and pilot tested in South Africa. The intervention is grounded in the experience of South African health service provider, empirical research on AIDS-related stigmas, and elements of a social cognitive theory of health behavior change. The intervention consists of a single 60-minute risk reduction counseling session delivered within the context of STI services. Participants will be STI clinic patients over age 18 that have been treated for a previous STI. Participants will be baseline assessed and randomized to receive either (a) the 60 min theory-based and culturally tailored risk reduction intervention or (b) a time and contact matched standard of care HIV and health education session. Participants will be followed for 12 months post intervention. Assessments will be conducted using computer assisted interviews (ACASI). The randomized trial will determine the efficacy of the risk reduction intervention for South African men and women receiving STI clinic services. Outcome analyses will include differences between conditions on new STI diagnoses over 12 months. We will also test the mediating effects of attitudes and beliefs on intervention outcomes. Results of this research will therefore test a clinic-based HIV prevention intervention model that is urgently needed in South Africa. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01242501
Study type	Interventional
Source	University of Connecticut
Contact
Status	Completed
Phase	N/A
Start date	August 1, 2016
Completion date	January 30, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01144871` - Parental Knowledge and Attitudes of Confidential Sexually Transmitted Infections (STI) Services for Teens	N/A
Completed	`NCT04661566` - Optimizing a Multi-Modal Intervention to Reduce Health-Risking Sexual Behaviors: Component Selection	N/A
Completed	`NCT01842100` - To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy	N/A
Completed	`NCT04867798` - Transgender Men and HIV in Uganda: PrEP Uptake and Persistence
Active, not recruiting	`NCT04328025` - Peer-Delivered HIV Self-Testing, STI Self-Sampling and PrEP for Transgender Women in Uganda	N/A
Completed	`NCT02509572` - Improvement of STI Detection in Adolescent Emergency Department Patients	N/A
Active, not recruiting	`NCT04758390` - A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women	N/A
Completed	`NCT03528135` - Project PRIDE (Promoting Resilience In Discriminatory Environments)	N/A
Recruiting	`NCT04547413` - STI/HIV Intervention Behavioral Intervention Program	N/A
Completed	`NCT02461940` - STI/HIV Prevention Intervention for Adolescents in Singapore	N/A
Completed	`NCT01784809` - The Multimedia HIV/STI Prevention for Drug-Involved Female Offenders	Phase 2
Completed	`NCT01136850` - Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea	Phase 3
Completed	`NCT00469547` - 62% & 15% Ethanol in Emollient Gel as Topical Male Microbicides	Phase 1
Completed	`NCT01285349` - HIV/STI Prevention for Drug-Involved Couples	N/A
Completed	`NCT02391233` - Multimedia WORTH With Black Drug-Involved Women on Probation	N/A
Completed	`NCT02183909` - Connecting Resources for Urban Sexual Health	N/A
Completed	`NCT02882607` - Peer Groups for Healthy Pregnancy & HIV Prevention for Young Malawian Women	N/A
Completed	`NCT00362375` - Evaluation of the Healthy Love Workshop, an HIV Prevention Intervention for African American Women	Phase 1/Phase 2
Active, not recruiting	`NCT04710784` - A Pragmatic Trial to Expand Youth-friendly HIV Self-testing	N/A
Recruiting	`NCT06223165` - Optimizing the Floreciendo Sexual and Reproductive Health Workshop for Latina Teens and Female Caregivers: A Pilot	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.